Refsum disease (heredopathia atactica polyneuritifor mis) was first described in 1946 and is a rare recessively Refsum's disease, also known as heredopathia atactic a polyneuritiformis is a rare cause of retinitis pigmentosa. It was first described by Sigvald Refsum in Norway in 1945.1 By 1984 there were at least 70 cases known2 and since then there have been over 30 more cases described. The disease is inherited as an autosomal recessive condition. Refsum described four cardinal manifestations: retinitis pigmen tosa, a chronic polyneuropathy, ataxia with other cerebellar signs, and a raised CSF protein in the absence of an increased cell count. 2 Additional features include anosmia, cataract, miosed unreactive pupils, deafness, ichthyosis, skeletal abnormalities and cardiac arrhythmias which have been postulated to be the cause of sudden death in acute exacerbations.3A In 1963 Klenk and Kahlke reported an association with raised blood serum phytanic acid
Eye (1992) 6,371-375 (3.7.11.15-tetramethylhexadecanoic acid) levels.5 Phy tanic acid is a fatty acid with methyl side chains and cannot be catabolised directly by the beta-oxidation process used by other fatty acids because of the steric hindrance of the methyl side chain at position 3 ( Fig. 1 ). It therefore depends on an initial alpha-oxidation and decarboxylation before beta-oxidation can metabolise the rest of the chain (Fig.  1 b) . By using other radio-labelled beta-methyl fatty acids Stokke et at' found that the initial alpha-oxidation and decarboxylation was affected in Refsum disease. Fatty acid catabolism can also be initiated from the non-carboxyl end of the chain by omega-oxidation (Fig. la) . In Refsum disease this becomes the only metabolic pathway for phy tanic acid. The capacity of this pathway is limited to only 10 mg phytanic acid a day and may vary between individ ualsY The average Western diet contains 50 mg phytanic acid, derived largely from dairy and ruminant fats: although unbound phytol can be metabolised to phytanic acid ( Fig.  1 ), in green vegetables it is bound to chlorophyll and so not easily absorbed in man. Therefore in Refsum disease phy tantic acid accumulates in the body and it is thought that this leads to the clinical manifestations of this disease. Indeed lipid deposits have been found in the pigment epithelium of the iris, ciliary body and retina as well as other tissues.9•10.11 Levy11 suggested that in the retinal pigment epithelium the excess phytanic acid may be erroneously incorporated during vitamin A esterification and the abnormal ester, incapable of being metabolised, accumulates leading to a lethal synthesis.
The mainstay of treatment is a diet low in phytanic acid and unbound phytol but sufficient in calories to prevent the release of endogenous phytanic acid from the body fat stores.12.13,14,15 During severe exacerbations, plasmaphere sis may be used to lower the phytanic acid level rapidly and prevent possible fatal sequelae.12,13,16 Treatment has been shown to improve the acute neurological and dermatolog ical signs. 4, 12, 15 Hansen reported that the progress of more chronic signs such as retinitis pigmentosa may also be halted. 17 Typically patients with Refsum disease first present before the age of 20 years with nyctalopia. However, their biochemical diagnosis is frequently delayed for at least a decade when the development of neurological symptoms, commonly a peripheral neuropathy, leads to a suspicion of Refsum disease. This paper reviews the presentation and ophthalmic histories of possibl y the largest series collected.
PATIENTS AND METHODS
Tw enty-three patients with biochemically proven Refsum disease have been seen in this unit. Their ophthalmic histo ries have been taken from a retrospective study of the hospi tal notes. Their average age was 40.3 years (range 25-65) with 12 men and 11 women. The mean follow-up from the time when Refsum disease was diagnosed was 7.5 years (range six months to 22 years).
RESULTS

Presentation of patients
The mean age at which this series of patients developed an n.l 
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initial symptom signifying the disease was 16 years (range 6-34 years) and Figure 2 illustrates the nature of these symptoms. In all but two patients the symptoms could be related to visual deterioration. Every case in this series has developed retinitis pigmentosa and the age at which this was diagnosed ranged from 6 to 46 years, average 23 years. All but two patients had presented to an ophthalmologist more than a year before a diagnosis of Refsum disease was made and in most cases the delay was much longer: mean 11 years, range one to 28 years. Figure 3 shows the time lag between the age at which the first symptom appeared, the age of presentation to an ophthalmologist with a certain diagnosis of retinitis pigmentosa, and the age at which Ref sum disease was finally diagnosed. The reason for suspect ing a diagnosis of Refs urn disease in this series of patients is shown in Figure 4 . Only one case was referred by an oph thalmologist. Of the rest, 15 were diagnosed by a neurol ogist on the basis of the patient developing an acute peripheral neuropathy and ataxia affecting walking and in some cases severe enough to render the patient wheelchair bound. One patient had a myocardial infarction at 37 years, two years before a definitive diagnosis was made. This group included the two patients who had not seen an oph thalomologist previously, despite both cases having severe retinitis pigmentosa at presentation. One patient was aware of her visual impairment but had not sought advice, the other was ignorant of her disability and despite her periph eral field being restricted to 10°, had been taking driving les sons! Four patients were diagnosed as a result of a positive family history, one was recognised from a genetic coun selling clinic and two referred themselves after reading an article on Refsum disease in the British Retinitis Pigmen tosa Society newsletter. Figure 5 shows the prevalence of the more commonly occurring associated features in our cohort of patients. The ichthyosis was present all over the body, in particular the knees, palms and back appearing as patches of dried flaky skin (Fig. 6 ). Typical skeletal abnormalities were bilateral shortening of the tubular bones of the hand and foot, in particular a short terminal phalanx of the thumb (Fig. 7 ).
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____ _ age at which presented to an ophthalmol�ist 10 --+--age at which Refsum's Disease was diagnosed The average serum phytanic acid at the time of diagnosis was 1361.3 micromol/l (SE 185.9 micromol/l; normal < 33 micromol/l). Seven patients had severe enough neu ropathy to warrant plasmapheresis in addition to the phy tanic acid restricted diet. The diet was divided into four stages: (1) liquid, phytanic acid free; (2) liquid and solid with minimal amounts of phytanic acid; (3) solid with> 10 mg phytanic acid a day; (4) solid with limited green vegetables.
Depending on the serum phytanic acid patients were started on diet stages 1, 2 or 3 but most were maintained on stage 4. Details of the plasmapheresis technique and diet have been described elsewere.13.14 The cumulative mean phytanic acid concentration is a measure of the phytanic acid concentration during the period of the study. The aver age cumulative mean phytanic acid concentration of all 23 patients was 659.5 micromol/l (SE 89.1 micromolol/1). In all cases the peripheral neuropathy and ataxia improved, but in cases with a severe prolonged neuropathy prior to diagnosis residual signs remain. The ichthyosis cleared with treatment. The oldest patient in the series died at 65 years of cor pulmonale associated with old pulmonary tuberculosis not thought to be related to Refsum disease.
In common with other autosomal conditions seven patients had affected siblings, but no other affected rela tives. In our series there were four brothers, a brother and 373 sister and another patient had an affected sister not included in the study. Four other patients had consanguineous parents.
OPHTHAL MOLOGICAL ASPECTS:
Retinitis Pigmentosa: All patients developed retinitis pig mentosa before they were diagnosed as having Refsum disease. In eight cases the pigmentation was described as atypical at first presentation, being distributed in patches, or scanty, or of the salt and pepper type. With time the pig mentation became more extensive.
Visual Fields: At the time of diagnosing Refsum disease the visual fields were severely restricted in most patients; 75% of eyes displayed fields of less than 200 and 80% of these were 10° or less. In five patients serial fields have been per formed from the time of first presentation to an ophthal mologist (Fig. 8) . As different perimeters were used for different fields even for a given subject, quantitative analy sis is not possible but in all but one patient there appears to be progressive deterioration.
Visual Acuity and Cataracts: Figure 9 shows a pair of scat tergrams displaying the visual acuity before and after treat ment for Refsum disease. In Figure 9a the visual acui t y measured by an ophthalmologist when retinitis pigmentosa was diagnosed was compared to the visual acuity measured at the time of diagnosis of Refsum disease. Data are avail able from 15 cases and in 23/30 eyes (76.7%) visual acuity deteriorated. However, there was no correlation between the visual acuity and serum phytanic acid level measured at diagnosis (r < 0.4). In Figure 9b the visual acuities were compared between the time of starting treatment and most recently recorded. Data are available for 17 patients and in contrast 14/34 eyes (41.2%) had further deterioration of acuity. Posterior subcapsular cataracts are common as in other forms of retinitis pigmentosa and 14 of 46 eyes have undergone cataract extraction. Visual acuity data are avail able from 12 eyes; nine have maintained or improved their acuity from the level it had reached when Refsum disease was diagnosed. In one patient a mature cataract dislocated below the visual axis and so far he has avoided a lens extrac tion. For the remaining phakic eyes there was no correlation Glaucoma: Four patients developed acute angle closure glaucoma; none of them were using mydriatics. A further two have been noted to have narrow drainage angles on gonioscopy. Refraction data were available on four cases and none were high hypermetropes (greatest = +0.75DS).
One case had biometry and the axial length was 21.8 mm.
Two patients had significant cataract and four had miosed pupils.
Five patients had a nystagmus at presentation which resolved with treatment. Twelve patients have had electro diagnostic studies. The VEPs showed an increased latency but normal amplitudes, the EOGs were flat and in seven cases who had ERGs four were flat and in the others there was severe reduction of both the photopic and scotopic response. In one case a second ERG measured after nine years treatment showed that the minimal response initially seen was lost. and ichthyosis. In positive cases a random serum phytanic acid level will be raised well above normal and is a reliable screening test.
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